Microwave-assisted synthesis of novel (5-nitropyridin-2-yl)alkyl and (5-nitropyridin-3-yl)alkyl carbamates

Journal of Organic Chemistry

Volumn 74, Issue 5, 2009, Pages 1932-1938

  Henry, Christophe ^a,b   Haupt, Andreas ^a   Turner, Sean C ^a  

^a ABBOTT GMBH AND CO KG   (Germany)

^b 4SC AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2-PYRIDONE; [CARBONYL; BUILDING BLOCKS; CARBONYL DERIVATIVES; MICROWAVE-ASSISTED SYNTHESIS; REGIOCHEMICAL; STARTING MATERIALS; STRUCTURAL PARAMETERS;

AMINES; CARBONYLATION; CHEMICAL MODIFICATION; MICROWAVE IRRADIATION; ORGANIC COMPOUNDS;

ALKYLATION;

1 METHYL 3,5 DINITRO 2 PYRIDONE; BENZYL 3,4 DIHYDRO 7 NITRO 2H PYRANO[3,2 B]PYRIDIN 3 YLCARBAMATE; BENZYL 5,6,7,8 TETRAHYDRO 3 NITROQUINOLIN 7 YLCARBAMATE; BENZYL 6,8 DIHYDRO 3 NITRO 5H PYRANO[3,4 B]PYRIDIN 5 YLCARBAMATE; BENZYL(5 NITROPYRIDIN 3 YL)METHYLCARBAMATE; CARBAMIC ACID DERIVATIVE; CARBONYL DERIVATIVE; NITROGEN; PYRIDONE DERIVATIVE; TERT BUTYL 2 (5 NITROPYRIDIN 2 YL)CYCLOPENTYLCARBAMATE; TERT BUTYL 2 (5 NITROPYRIDIN 2 YL)PYRROLIDINE 1 CARBOXYLATE; TERT BUTYL 2 (5 NITROPYRIDIN 2 YL)THIAZOLIDINE 3 CARBOXYLATE; TERT BUTYL 2 (5 NITROPYRIDIN 3 YL)PYRROLIDINE 1 CARBOXYLATE; TERT BUTYL 3 NITRO 5H PYRROLO[3,4 B]PYRIDINE 6 (7H)CARBOXYLATE; TERT BUTYL 5,6 DIHYDRO 3 NITRO 1,7 NAPHTHYRIDINE 7(8H)CARBOXYLATE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; MICROWAVE IRRADIATION; POLYMERIZATION;

CARBAMATES; CYCLIZATION; MICROWAVES; MOLECULAR STRUCTURE; PYRIDINES; STEREOISOMERISM;

EID: 64249144010     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo802439d     Document Type: Article

References (49)

1. Data collected in the Investigational Drugs database, copyright Thomson Reuters.
2. Gu, W.-Z.; Tahir, S. K.; Wang, Y.-C.; Zhang, H.-C.; Cherian, S. P.; O'Connor, S.; Leal, J. A.; Rosenberg, S. H.; Ng, S.-C. Eur. J. Cancer 1999, 35, 1394-1401.
3. Quan, M. L.; Chiu, A. T.; Ellis, C. D.; Wong, P. C.; Wexler, R. R.; Timmermans, P. B. M. W. M. J. Med. Chem, 1995, 38, 2938-2945.
4. Ganellin, C. R.; Hosseini, S. K.; Khalaf, Y. S.; Tertiuk, W.; Harrang, J.-M.; Garbarg, M.; Ligneau, X.; Schwartd. J.-C. J. Med. Chem. 1995, 38, 3342-3350.
5. El Saved, K. A.; Kelly, M.; Kara, U. A. K.; Ang, K. K. H.; Katsuyama, I.; Dunber, D. C.; Khan, A. A.; Hamann, M. T. J. Am. Chem. Soc. 2001, 123, 1804-1808, and references therein.
6. Oku, N.; Matsunaga, S.; Fusetani, N. J. Am. Chem. Soc. 2003, 125, 2044-2045.
7. Schupp, P.; Pochner, T.; Edrada, R.; Ebel, R.; Berg, A.; Wray, V.; Proksch, P. J. Nat. Prod. 2003, 66, 272-275. and references therein.
8. (a) Bakke, J. M.; Ranes, E. Synthesis 1997, 3, 281-283.
9. (b) Bakke, J. M.; Ranes, E.; Riha, J.; Svensen, H. Acta Chem. Scand. 1999, 53, 141-144.
10. (c) Murashima, T.; Nishi, K.; Nakamoto, K.-I.; Kato, A.; Tamai, R.; Uno, H.; Ono, N. Heterocycles 2002, 58, 301-310.
11. (d) Murugan, R.; Scriven, E. F. V.; Hillstrom, G. F.; Ghoshal, P. K. PCT Int. Appl. WO 02/090328 Al: Chem. Abstr. 2002, 137, 352895.
12. (e) Provencal, D. P.; Gesenberg, K. D.; Wang, H.; Escobar, C.; Wong, H.; Brown, M. A.; Staab, A. J.; Pendri, Y. R. Org. Process Res. Dev. 2004, 8, 903-908.
13. (f) Katritzky, A. R.; Scriven, E. F. V.; Majumder, S.; Akhmedova, R. G.; Vakulenko, A. V.; Akhmedov, N. C.; Murugan. R.; Abboud, K. A. Org. Biomol. Chem, 2005, 3, 538-541.
14. (a) Marcoux, J.-F.; Corley, E. G.; Rossen, K.; Pye, P.; Wu, J.; Robbins, M. A.; Davies, I. W.; Larsen, R. D.; Reider, P. J. Org. Lett. 2000, 2, 2339-2341.
15. (b) Davies, I. W.; Marcoux, J.-F.; Wu, J.; Palucki, M.; Corley, E. C.; Robbins, M.; Tsou, N.; Ball, R. C.; Dormer, P.; Larsen, R. D.; Reider, P. J. Org. Chem. 2000, 65, 4571-4574.
16. Tohda, Y.; Eiraku, M.; Nakagawa, T.; Usami, Y.; Ariga, M.; Kawashima, T.; Tani, K.; Watanabe, H.; Mori, Y. Bull. Chem. Soc. Jpn. 1990, 63, 2820-2827.
17. (a) Takada, S.; Sasatani, T.; Chomei, N.; Adachi, M.; Fujishita, T.; Eigyo, M.; Murata, S.; Kawasaki, K.; Matsushita, A. J. Med. Chem. 1996, 39, 2844-2851.
18. (b) Harling, J. D.; Harrington, F. P.; Thompson, M. Synth. Commun. 2001, 31, 787-797.
19. (c) Ananthan, S.; Kezar, H. S.; Saini, S. K.; Khare, N. K.; Davis, P.; Dersch, C. M.; Porreca, F.; Rothman, R. B. Bioorg. Med. Chem, Lett. 2003, 13, 529-532.
20. (d) Austin, N. E.; Hadley, M. S.; Harling, J. D.; Hanington, F. P.; Macdonald, G. J.; Mitchell, D. J.; Rile'y, G. J.; Stean, T. O.; Stemp, G.; Stratton, S. C.; Thompson, M.; Upton, N. Bioorg. Med. Chem. Lett. 2003, 13, 1627-1629.
21. (e) Jiao, R.; Butora, G.; Goble, S. D.; Guiadeen, D.; Mills, S. G.; Moriello, G.; Pasternak, A.; Tang, C.; Yang, L.; Zhou, C.; Kothandaraman, S.; Moves, C. U.S. Patent Appl. US 2005/0107422 Al; Chem. Abstr. 2005, 142, 482030.
22. (f) Nishiwaki, N.; Tatsumichi, H.; Tamura, M.; Ariga, M. Lett. Org. Chem. 2006, 3, 629-633.
23. (g) Vara Prasad, J. V. N.; Boyer, F. E.; Chupak, L.; Dermyer, M.; Ding, Q.; Gavardinas, K.; Hagen, S. E.; Huband, M. D.; Jiao, W.; Kaneko, T.; Maiti, S. N.; Melnick, M.; Romero, K.; Patterson, M.; Wu, X. Bioorg. Med. Chem. Lett. 2006, 16, 5392-5397.
24. (h) Drescher, K.; Haupt, A.; Unger, L.; Turner, S. C.; Braje, W.; Grandel, R.; Henry. C. PCT Int. Appl. WO 2006/040178 Al; Chem. Abstr. 2006, 144. 412247.
25. (a) Nahm, S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815-3818.
26. (b) Fehrentz, J.-A.; Castro, B. Synthesis 1983, 8, 676-678.
27. (a) Kobayashi, S.; Kakumoto, K.; Sugiura, M. Org. Lett. 2002, 4, 1319-1322.
28. (b) Wabnitz, T. C.; Spencer, J. B. Tetrahedron Lett. 2002, 43, 3891-3894.
29. (c) Srivastava, N.; Banik, B. K. J. Org. Chem. 2003, 68, 2109-2114.
30. Rouden, J.; Seitz, T.; Lemoucheux, L.; Lasne, M.-C. J. Org. Chem. 2004, 69, 3787-3793.
31. For the preparation of 2a, see: Goldstein, S. W.; Overman, L. E.; Rabinowitz, M. H. J. Org. Chem. 1992, 57, 1179-1190.
32. For the preparation of 2c, see: Aoyagi, S.; Wang, T.-C.; Kibayashi, C. J. Am. Chem. Soc. 1993, 115, 11393-11409.
33. 3CN, DMF, or pyridine did not significantly improve the condensation outcomes.
34. Kuhnert, N. Angew. Chem., Int. Ed. 2002, 41, 1863-1866.
35. Toujas, J.-L.; Jost, E.; Vaultier, M. Bull. Soc Chim. Fr. 1997, 134, 713-717.
36. Nagafuji, P.; Cushman, M. J. Org. Chem. 1996, 61, 4999-5003.
37. For the preparation of 9a, see: (a) Ninomiya, K.; Shioiri, T.; Yamada, S. Tetrahedron 1974, 30, 2151-2157.
38. (b) Gaunt, M. J.; Spencer, J. B. Org. Lett. 2001, 3, 25-28.
39. For the preparation of 9b, see: (a) Xu. L.-W.; Xia. C.-G.; Hu, X.-X. Chem. Commun. 2003, 20, 2570-2571.
40. (b) Xu, L.-W.; Xia, C.-G. Tetrahedron Lett. 2004, 45, 4507-4510.
41. (a) Mavandadi, F.; Lidstrom, P. Curr. Top. Med. Chem. 2004, 4, 773-792.
42. (b) Kappe, C. O.; Stadler, A. In Microwaves in Organic and Medicinal Chemistry; Mannhold, R., Kubinyi, H., Folkers, C., Eds.; Wiley-VCH: Werlag GmbH & Co. KGaA: Weinheim Germany, 2005.
43. (c) Kappe, C. O.; Dallinger, D. Nat. Rev. Drug Discovery 2006, 5, 51-63.
44. For examples of microwave-assisted synthesis of heterocycles, see: (a) Zhao, Z.; Wisnoski, D. D.; Wolkenberg, S. E.; Leister, W. H.; Wang, Y.; Lindsley, C. W. Tetrahedron Lett. 2004, 45, 4873-4876.
45. (b) Siu, J.; Baxendale, I. R.; Ley- S. V. Org. Biomol. Chem. 2004, 2, 160-167.
46. (c) Sandin, H.; Swanstein, M.-L.; Wellner, E. J. Org. Chem. 2004, 69, 1571-1580.
47. (d) Sparks, R. B.; Combs, A. P. Org. Lett. 2004, 6, 2473-2475.
48. (e) Schirok, H. J. Org. Chem, 2006, 71, 5538-5545.
49. The preparation of 9d started from the corresponding 2H-pyran-3(6H)-one, which had to be synthesized according to: Eiden, F.; Wanner. K. T. Arch. Pharm. 1985, 318, 548-555.